Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy.
Adolescent
Adult
Aged
Aged, 80 and over
COVID-19
/ epidemiology
Cardiovascular Diseases
/ epidemiology
Comorbidity
Diabetes Mellitus
/ epidemiology
Female
Hospital Mortality
Hospitalization
Humans
Hypertension
/ epidemiology
Italy
/ epidemiology
Male
Middle Aged
Neoplasms
/ epidemiology
Retrospective Studies
SARS-CoV-2
COVID-19
Coronavirus
Diabetes
Mortality
SARS-CoV-2
Journal
Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
05
06
2020
accepted:
31
07
2020
pubmed:
11
8
2020
medline:
18
3
2021
entrez:
11
8
2020
Statut:
ppublish
Résumé
The purpose of this study was to evaluate the impact of pre-existing diabetes on in-hospital mortality in patients admitted for Coronavirus Disease 2019 (COVID-19). This is a single center, retrospective study conducted at Policlinico di Monza hospital, located in the Lombardy region, Northern Italy. We reviewed medical records of 373 consecutive adult patients who were hospitalized with COVID-19 between February 22 and May 15, 2020. Data were collected on diabetes status, comorbid conditions and laboratory findings. Multivariable logistic regression was performed to evaluate the effect of diabetes on in-hospital mortality after adjustment for potential confounding variables. Mean age of the patients was 72 ± 14 years (range 17-98), 244 (65.4%) were male and 69 (18.5%) had diabetes. The most common comorbid conditions were hypertension (237 [64.8%]), cardiovascular disease (140 [37.7%]) and malignant neoplasms (50 [13.6%]). In-hospital death occurred in 142 (38.0%) patients. In the multivariable model older age (Relative Risk [RR] 1.06 [1.04-1. 09] per year), diabetes (RR 1.56 [1.05-2.02]), chronic obstructive pulmonary disease (RR 1.82 [1.13-2.35]), higher values of lactic dehydrogenase and C-reactive protein were independently associated with in-hospital mortality. In this retrospective single-center study, diabetes was independently associated with a higher in-hospital mortality. More intensive surveillance of patients with this condition is to be warranted.
Identifiants
pubmed: 32776197
doi: 10.1007/s40618-020-01382-7
pii: 10.1007/s40618-020-01382-7
pmc: PMC7415410
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
843-850Références
Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahl GL, Saemundsdottir J, Sigurdsson A, Sulem P, Agustsdottir AB, Eiriksdottir B, Fridriksdottir R, Gardarsdottir EE, Georgsson G, Gretarsdottir OS, Gudmundsson KR, Gunnarsdottir TR, Gylfason A, Holm H, Jensson BO, Jonasdottir A, Jonsson F, Josefsdottir KS, Kristjansson T, Magnusdottir DN, le Roux L, Sigmundsdottir G, Sveinbjornsson G, Sveinsdottir KE, Sveinsdottir M, Thorarensen EA, Thorbjornsson B, Löve A, Masson G, Jonsdottir I, Möller AD, Gudnason T, Kristinsson KG, Thorsteinsdottir U, Stefansson K (2020) Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med. https://doi.org/10.1056/NEJMoa2006100
doi: 10.1056/NEJMoa2006100
pubmed: 33147384
pmcid: 7494247
Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323(13):1239–1242. https://doi.org/10.1001/jama.2020.2648
doi: 10.1001/jama.2020.2648
Gentile S, Strollo F, Ceriello A (2020) COVID-19 infection in Italian people with diabetes: lessons learned for our future (an experience to be used). Diabetes Res Clin Pract 162:108137. https://doi.org/10.1016/j.diabres.2020.108137
doi: 10.1016/j.diabres.2020.108137
pubmed: 32259611
pmcid: 7270733
Dombrowski NC, Karounos DG (2013) Pathophysiology and management strategies for hyperglycemia for patients with acute illness during and following a hospital stay. Metabolism 62(3):326–336. https://doi.org/10.1016/j.metabol.2012.07.020
doi: 10.1016/j.metabol.2012.07.020
pubmed: 22999713
Targher G, Mantovani A, Wang XB, Yan HD, Sun QF, Pan KH, Byrne CD, Zheng KI, Chen YP, Eslam M, George J, Zheng MH (2020) Patients with diabetes are at higher risk for severe illness from COVID-19. Diabetes Metab. https://doi.org/10.1016/j.diabet.2020.05.001
doi: 10.1016/j.diabet.2020.05.001
pubmed: 33296704
pmcid: 7255326
Huang I, Lim MA, Pranata R (2020) Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia—a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 14(4):395–403. https://doi.org/10.1016/j.dsx.2020.04.018
doi: 10.1016/j.dsx.2020.04.018
pubmed: 32334395
pmcid: 7162793
Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, Qin R, Wang H, Shen Y, Du K, Zhao L, Fan H, Luo S, Hu D (2020) Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. https://doi.org/10.1002/dmrr.3319
doi: 10.1002/dmrr.3319
pubmed: 33275827
pmcid: 33275827
Shi Q, Zhang X, Jiang F, Zhang X, Hu N, Bimu C, Feng J, Yan S, Guan Y, Xu D, He G, Chen C, Xiong X, Liu L, Li H, Tao J, Peng Z, Wang W (2020) Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study. Diabetes Care. https://doi.org/10.2337/dc20-0598
doi: 10.2337/dc20-0598
pubmed: 33355246
Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, Southern WN, Mantzoros CS (2020) Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metab Clin Exp. https://doi.org/10.1016/j.metabol.2020.154262
doi: 10.1016/j.metabol.2020.154262
pubmed: 32422233
pmcid: 7228874
Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, Aaron JG, Claassen J, Rabbani LE, Hastie J, Hochman BR, Salazar-Schicchi J, Yip NH, Brodie D, O’Donnell MR (2020) Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 395(10239):1763–1770. https://doi.org/10.1016/S0140-6736(20)31189-2
doi: 10.1016/S0140-6736(20)31189-2
pubmed: 32442528
pmcid: 7237188
Sardu C, D’Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, Maggi P, Coppola N, Paolisso G, Marfella R (2020) Outcomes in patients with hyperglycemia affected by Covid-19: can we do more on glycemic control? Diabetes Care. https://doi.org/10.2337/dc20-0723
doi: 10.2337/dc20-0723
pubmed: 32430456
pmcid: 7305003
D'Agostino RB (1971) An omnibus test of normality for moderate and large size samples. Biometrika 58(2):341–348. https://doi.org/10.2307/2334522
doi: 10.2307/2334522
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
doi: 10.1016/S0140-6736(20)30566-3
pubmed: 32171076
pmcid: 7270627
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc: Ser B (Methodol) 57(1):289–300
Zhang Y, Cui Y, Shen M, Zhang J, Liu B, Dai M, Chen L, Han D, Fan Y, Zeng Y, Li W, Lin F, Li S, Chen X, Pan P (2020) Association of diabetes mellitus with disease severity and prognosis in COVID-19: a retrospective cohort study. Diabetes Res Clin Pract. https://doi.org/10.1016/j.diabres.2020.108227
doi: 10.1016/j.diabres.2020.108227
pubmed: 33359751
pmcid: 7833744
Fadini GP, Morieri ML, Longato E, Avogaro A (2020) Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest 43(6):867–869. https://doi.org/10.1007/s40618-020-01236-2
doi: 10.1007/s40618-020-01236-2
pubmed: 32222956
Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C, Liu C, Xiong M, Deng A, Zhang Y, Zheng L, Huang K (2020) Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. https://doi.org/10.2337/dc20-0660
doi: 10.2337/dc20-0660
pubmed: 33355246
pmcid: 7818327
Angelidi AM, Belanger MJ, Mantzoros CS (2020) COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next. Metabol Clin Exp. https://doi.org/10.1016/j.metabol.2020.154245
doi: 10.1016/j.metabol.2020.154245
Joshi N, Caputo GM, Weitekamp MR, Karchmer A (1999) Infections in patients with diabetes mellitus. N Engl J Med 341(25):1906–1912
doi: 10.1056/NEJM199912163412507
Geerlings SE, Hoepelman AI (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26(3–4):259–265
doi: 10.1111/j.1574-695X.1999.tb01397.x
Berbudi A, Rahmadika N, Cahyadi A, Ruslami R (2019) Type 2 Diabetes and its Impact on the Immune System. Curr Diab Rep 16(5):442–449. https://doi.org/10.2174/1573399815666191024085838
doi: 10.2174/1573399815666191024085838
Chen X, Hu W, Ling J, Mo P, Zhang Y, Jiang Q, Ma Z, Cao Q, Deng L, Song S (2020) Hypertension and diabetes delay the viral clearance in COVID-19 patients. medRxiv. https://doi.org/10.1101/2020.03.22.20040774
Fadini GP, Morieri ML, Longato E, Bonora BM, Pinelli S, Selmin E, Voltan G, Falaguasta D, Tresso S, Costantini G, Sparacino G, Di Camillo B, Tramontan L, Cattelan AM, Vianello A, Fioretto P, Vettor R, Avogaro A (2020) Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case–control study. Diabetes Obes Metab. https://doi.org/10.1111/dom.14097
doi: 10.1111/dom.14097
pubmed: 32691492
pmcid: 7283835
Bonnet F, Scheen AJ (2018) Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: the potential contribution to diabetes complications and cardiovascular disease. Diabetes Metab 44(6):457–464. https://doi.org/10.1016/j.diabet.2018.09.005
doi: 10.1016/j.diabet.2018.09.005
pubmed: 30266577
Bossi AC, Forloni F, Colombelli PL (2020) Lack of efficacy of SGLT2-i in severe pneumonia related to novel coronavirus (nCoV) infection: no little help from our friends. Diabetes Ther. https://doi.org/10.1007/s13300-020-00844-8
doi: 10.1007/s13300-020-00844-8
pubmed: 33052537
pmcid: 7434823
Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G (2020) Renin–angiotensin–aldosterone system blockers and the risk of Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMoa2006923
doi: 10.1056/NEJMoa2006923
pubmed: 33108106
pmcid: 33108106
Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M, Cicero AFG, Minuz P, Muiesan ML, Mulatero P, Mulè G, Pucci G, Savoia C, Sechi L, Carugo S, Fallo F, Giannattasio C, Grassi D, Letizia C, Perlini S, Rizzoni D, Sarzani R, Tocci G, Veglio F, Rosei CA, Bevilacqua M, Bisogni V, Bombelli M, Bulfone L, Canichella F, Carpani G, Catanuso M, Chiarini G, Chiumiento F, Cianci R, Cipollini F, Concistrè A, Dalbeni A, Blasi RAD, Ciuceis CD, Dell’Oro R, Guardo AD, Lorenzo SD, Norcia MD, Ervo R, Eula E, Fabbricatore D, Fanelli E, Fava C, Grasso E, Grimaldi A, Illario M, Invernizzi C, Iraca E, Liegi F, Malerba P, Maloberti A, Mancusi C, Molinari G, Mussinelli R, Paini A, Pellimassi P, Piazza O, Pontremoli R, Tevano FQ, Rabbia F, Rocco M, Sabena A, Salinaro F, Schiavi P, Sgariglia MC, Spannella F, Tedeschi S, Viale P (2020) Age and multimorbidity predict death among COVID-19 patients. Hypertension 76(2):366–372. https://doi.org/10.1161/HYPERTENSIONAHA.120.15324
doi: 10.1161/HYPERTENSIONAHA.120.15324
pubmed: 32564693
Covino M, De Matteis G, Santoro M, Sabia L, Simeoni B, Candelli M, Ojetti V, Franceschi F (2020) Clinical characteristics and prognostic factors in COVID-19 patients aged≥ 80 years. Geriatr Gerontol Int 20(7):704–708. https://doi.org/10.1111/ggi.13960
doi: 10.1111/ggi.13960
pubmed: 32516861